## MOH: Molina Healthcare Inc - XLV: Healthcare

### Executive Summary

PARABOLIC warning: MRS_20 at 13.2% exceeds exhaustion threshold (10.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($156.86)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_20 drops below exhaustion threshold

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 4)

**1. AQR Capital Management LLC Acquires 40,714 Shares of Molina Healthcare, Inc $MOH**
- Source: MarketBeat | 20251213T085225 | Somewhat-Bearish | Relevance: 100%
- AQR Capital Management LLC has increased its stake in Molina Healthcare, Inc. by 4.6%, purchasing an additional 40,714 shares to now own 925,672 shares valued at $273.1 million. Despite this increased institutional interest, Molina Healthcare missed its quarterly EPS expectations, and several analysts have recently lowered price targets and ratings, leading to an average "Hold" consensus. The company, which provides managed healthcare services, has a market capitalization of $9.13 billion and a P/E ratio of 10.43.

**2. Molina Healthcare Stock (NYSE: MOH) News on Dec. 12, 2025: Rally Extends as ACA Subsidy Deadline, 2026 Outlook, and Analyst Forecasts Collide**
- Source: ts2.tech | 20251212T170827 | Neutral | Relevance: 100%
- Molina Healthcare (NYSE: MOH) stock experienced a rally on December 12, 2025, driven by a multi-day rebound, a new partnership with Aeroflow Health, and policy discussions around ACA subsidies. The company's 2025 earnings have been impacted by elevated medical costs, particularly in the Marketplace segment, leading to a revised outlook and analyst price target adjustments. Investors are closely watching the company's formal 2026 guidance for clarity on margin stabilization and repricing efforts.

**3. Why Molina Healthcare (MOH) Stock Is Trading Up Today**
- Source: Finviz | 20251211T221023 | Somewhat-Bullish | Relevance: 100%
- Molina Healthcare (MOH) stock jumped 4.5% after announcing a partnership with Aeroflow Health to expand virtual diabetes care and nutrition counseling in South Carolina for its Commercial and Medicare members. This news was positively received by investors, signaling an expansion of care offerings despite the company's recent challenges, including declining Medicaid membership and rising operating expenses. The stock had previously experienced significant underperformance, hitting a 52-week low and falling 41.5% since the beginning of the year.

**4. MOH, Aeroflow Team Up to Offer Virtual Diabetes Care in South Carolina**
- Source: TradingView | 20251211T180841 | Bullish | Relevance: 100%
- Molina Healthcare of South Carolina (MOH) has partnered with Aeroflow Health to provide virtual nutrition counseling and Diabetes Self-Management Education (DSME) services to its Commercial and Medicare members in South Carolina. This collaboration aims to help members manage blood sugar levels, adopt healthy lifestyles, and reduce diabetes-related complications through personalized virtual support from licensed dietitians and certified diabetes care specialists. The initiative is expected to strengthen Molina Healthcare's presence in South Carolina and attract new members by offering convenient, high-quality virtual care for chronic conditions.

**5. Bronstein, Gewirtz & Grossman, LLC Is Investigating Molina Healthcare, Inc. (MOH) And Encourages Stockholders to Connect**
- Source: WPRI.com | 20251214T160823 | Somewhat-Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (MOH) on behalf of investors who purchased securities before February 5, 2025, and still hold them. The investigation focuses on whether Molina, its officers, and/or directors engaged in corporate wrongdoing. The firm encourages affected stockholders to contact them to assist with the investigation.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Wells Fargo | $165 | $231 | -29% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($0.44M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Valuation risk: PEG 2.6x with declining EPS estimates leaves no margin for error.
2. Elevated short interest (11.4%): bears positioning against stock.
3. Long-term trend broken: trading 27.9% below SMA200.
4. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Momentum building: MRS_20 improving +7.3% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.62 signals overvaluation risk, limited margin of safety. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $9.1B |
| Beta | 0.52 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 11.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.62 |
| Forward P/E | 12.5 |
| Current P/E | 12.1 |
| YoY Growth | -2.9% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 5.8% to 13.2% (+7.3% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (13.2% > 10.0%), caution on chasing. MRS_5 at 5.6% confirms short-term momentum alignment. AM_20 at 13.5% shows strong absolute momentum above own 20MA. Outperforming sector by 13.4pp, stock-specific strength. Below SMA200 (0.72x), long-term trend not supportive. MACD histogram positive (3.71), confirming momentum. OFD pattern: +DBN (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 13.15% (CS: 97) | Strong |
| RSI_14 | 67.5 | Neutral |
| MACD Histogram | 3.71 | Bullish |
| vs SMA20 | 1.135x | Above |
| vs SMA50 | 1.034x | Above |
| vs SMA200 | 0.721x | Below |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $168.50
- **Stop Loss:** $156.86 (6.9% risk)
- **Target:** $180.14 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 85
- **Position Value:** $14,322.50
- **Portfolio %:** 14.32%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*